HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Changes in Implantation Patterns and Therapy Rates of Implantable Cardioverter Defibrillators over Time in Ischemic and Dilated Cardiomyopathy Patients.

AbstractBACKGROUND:
Clinical guidelines on implantable cardioverter defibrillator (ICD) therapy changed significantly in the last decades with potential inherent effects on therapy efficacy. We aimed to study therapy rates in time and the association between therapies and mortality.
METHODS:
All patients receiving an ICD, primary and secondary prevention, were included in a single-center retrospective registry. Information on first appropriate and inappropriate therapies was documented. Dates of implant were divided in P1: 1996-2001, P2: 2002-2008, and P3: 2009-2014.
RESULTS:
A total of 727 patients, 84.9% male-66.4% ischemic cardiomyopathy (ICM)-56% primary prevention-mean follow-up 5.2 ± 4.1 years, were included. There was a shift from secondary to primary prevention indications, from ischemic to non-ICM, and from single chamber to cardiac resynchronization therapy defibrillator devices. The annual 1- and 3-year appropriate shock (AS) rate declined from 29.4% and 15.1% in P1, over 13.3% and 9.2% in P2 to 7.8% and 5.7% in P3 (log-rank P < 0.001), while inappropriate shock (IAS) rates remained unchanged (log-rank P = 0.635). After multivariate regression analysis a higher age at implant, lower left ventricular ejection fraction, history of stroke, diabetes mellitus, intake of loop diuretics or digitalis, higher creatinine, and longer QTc were independent predictors of mortality.
CONCLUSION:
These changes in clinical practice with a shift to primary prevention and rise in non-ICM implants caused a significant decrease in AS incidence, while IAS remained stable. Receiving AS or IAS was not an independent predictor of mortality in our real-life cohort.
AuthorsBert Vandenberk, Christophe Garweg, Gabor Voros, Vincent Floré, Thomas Marynissen, Christian Sticherling, Markus Zabel, Joris Ector, Rik Willems
JournalPacing and clinical electrophysiology : PACE (Pacing Clin Electrophysiol) Vol. 39 Issue 8 Pg. 848-57 (Aug 2016) ISSN: 1540-8159 [Electronic] United States
PMID27198580 (Publication Type: Journal Article)
Copyright© 2016 Wiley Periodicals, Inc.
Topics
  • Age Distribution
  • Aged
  • Belgium (epidemiology)
  • Cardiomyopathy, Dilated (mortality, prevention & control)
  • Defibrillators, Implantable (statistics & numerical data)
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Myocardial Ischemia (mortality, prevention & control)
  • Practice Patterns, Physicians' (statistics & numerical data, trends)
  • Prevalence
  • Prosthesis Implantation (mortality, statistics & numerical data, trends)
  • Retrospective Studies
  • Risk Factors
  • Survival Rate
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: